Three US carriers lead naval drill aimed at N. Korea

Agencies
November 11, 2017

Seoul, Nov 11: South Korean warships joined three US aircraft carriers Saturday in an unusually strong display of naval force aimed at North Korea, whose nuclear ambitions have been a focus of US President Donald Trump's ongoing tour of Asia.

The four-day joint exercise in the western Pacific involves three flattops -- USS Ronald Reagan, USS Nimitz and USS Theodore Roosevelt -- and seven South Korean warships including three destroyers, Seoul's defence ministry said.

It is the first such triple-carrier drill in the region for a decade.

"The exercise is aimed at enhancing deterrence against North Korea's nuclear and missile threats and showing off preparedness to fend off any provocative acts by the North," a ministry spokesman said.

Nuclear-armed North Korea regularly denounces such military drills as rehearsals for invasion and sometimes conducts its own military manoeuvres or missile tests in response.

The US warships will carry out air defence drills, sea surveillance, defensive air combat training and other training operations, the US Navy said.

The exercises come on the heels of Trump's visits to Seoul and Beijing this week, which were dominated by the question of how to counter Pyongyang's nuclear weapons threat.

In a speech to the South Korean parliament on Wednesday, Trump warned North Korea not to underestimate the United States, while offering leader Kim Jong-Un a better future if he gives up his nuclear ambitions.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 8,2024

covid.jpg

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.